Electrocardiographic characteristics of bladder cancer patients receiving preoperative chemotherapy combined with immunotherapy DOI Creative Commons
Ziliang Chen, Kaipeng Jia, Yi Zheng

et al.

Annals of Noninvasive Electrocardiology, Journal Year: 2024, Volume and Issue: 29(1)

Published: Jan. 1, 2024

Abstract Objective Patients treated with preoperative chemotherapy and immunotherapy for bladder cancer may be at increased risk of cardiotoxicity electrophysiological abnormalities. This study aimed to analyze their electrocardiographic (ECG) alterations. Methods who were hospitalized receiving tislelizumab plus nab‐paclitaxel (TnP) enrolled prospectively. ECG, cardiac biomarkers, echocardiography performed baseline the end TnP. Results A total 60 patients (76.7% males), including 30 muscle‐invasive non‐muscle‐invasive cancer, received three or four cycles TnP, respectively. Hypertension was commonest comorbidity (41.7%), 25 (41.7%) prescribed cardiovascular drugs. In comparison characteristics, troponin I (cTnI) N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) within normal ranges after However, echocardiographic parameter left ventricular ejection fraction slightly decreased TnP (62.81 ± 3.81% 61.10 4.37%, p = .011). The incidence abnormal ECG from 65.0% 76.7%, which only a higher prevalence fragmented QRS (fQRS) observed (33.3% 50.0%, .013; mainly in inferior leads). parameters QT dispersion (QTd) prolonged significantly regimen (39.50 11.37 44.20 15.85 ms, .019). Conclusion combined immunotherapy, main abnormality fQRS QTd, relatively biomarkers parameters. Regular screening should carried out carefully detect potential long‐term follow‐up.

Language: Английский

Cardio-Oncology: A Myriad of Relationships Between Cardiovascular Disease and Cancer DOI Creative Commons
Yinghui Wang,

Yonggang Wang,

Xiaorong Han

et al.

Frontiers in Cardiovascular Medicine, Journal Year: 2022, Volume and Issue: 9

Published: March 17, 2022

Cardiovascular disease (CVD) and cancer are the leading causes of death worldwide. With an increasing number elderly population, early screening treatment, cancers cases rising, while mortality rate is decreasing. However, survivors yearly. prolonged life span patients, adverse effects anti-tumor therapy, especially CVD, have gained enormous attention. The incidence cardiovascular events such as cardiac injury or toxicity higher than malignant tumors' recurrence rate. Numerous clinical studies also shifted their focus from study a single to interdisciplinary oncology cardiology. Previous confirmed that therapy can cause CVD. Additionally, treatment CVD related tumors incidence. It well established increased in patients probably due unmodified unhealthy lifestyle among cardiotoxicity caused by anti-cancer therapy. Nevertheless, some with relatively risk because highly overlapping factors, including gender, age, hypertension, diabetes, hyperlipidemia, inflammation, obesity. advancements diagnosis many simultaneously suffer cancer, most them poor prognosis. Therefore, clinicians should understand relationship between tumors, effectively identify primary secondary prevention for these diseases, follow proper methods.

Language: Английский

Citations

48

Substances of Natural Origin in Medicine: Plants vs. Cancer DOI Creative Commons
Adrianna Gielecińska, Mateusz Kciuk, Somdutt Mujwar

et al.

Cells, Journal Year: 2023, Volume and Issue: 12(7), P. 986 - 986

Published: March 23, 2023

Continuous monitoring of the population’s health is main method learning about disease prevalence. National and international data draw attention to persistently high rates cancer incidence. This necessitates intensification efforts aimed at developing new, more effective chemotherapeutic chemopreventive drugs. Plants represent an invaluable source natural substances with versatile medicinal properties. Multidirectional activities exhibited by their ability modulate key signaling pathways, mainly related cell death, make these important research direction. review summarizes information regarding plant-derived drugs, including mechanisms action, a special focus on selected anti-cancer drugs (paclitaxel, irinotecan) approved in clinical practice. It also presents promising plant-based drug candidates currently being tested preclinical trials (betulinic acid, resveratrol, roburic acid).

Language: Английский

Citations

35

Biomimetic redox-responsive prodrug micelles with diselenide linkage for platinum nanozymes augmented sonodynamic/chemo combined therapy of colon cancer DOI

Yuanru Zhao,

Jingwen Xu, Yuanyuan Zhang

et al.

Chemical Engineering Journal, Journal Year: 2023, Volume and Issue: 472, P. 144911 - 144911

Published: July 19, 2023

Language: Английский

Citations

29

Anticancer therapy-induced peripheral neuropathy in solid tumors: diagnosis, mechanisms, and treatment strategies DOI
Jiahong Jiang, Luna Jia Zhan, Bo Jiang

et al.

Cancer Letters, Journal Year: 2025, Volume and Issue: unknown, P. 217679 - 217679

Published: March 1, 2025

Language: Английский

Citations

1

Microtubules and Cell Division: Potential Pharmacological Targets in Cancer Therapy DOI

Jomon Sebastian,

Krishnan Rathinasamy

Current Drug Targets, Journal Year: 2023, Volume and Issue: 24(11), P. 889 - 918

Published: July 31, 2023

Microtubules are a well-known target in cancer chemotherapy because of their critical role cell division. Chromosome segregation during mitosis depends on the establishment mitotic spindle apparatus through microtubule dynamics. The disruption dynamics stabilization or destabilization microtubules results arrest cells. Microtubule-targeted drugs, which interfere with dynamics, inhibit growth cells at phase and induce apoptotic death. principle microtubule-targeted drugs is to reduce disease unchecked proliferation. Many anti-microtubule agents produce significant inhibition widely used as chemotherapeutic for treatment cancer. that interact generally bind one three sites vinblastine site, taxol colchicine site. Colchicine binds interface tubulin heterodimer induces depolymerization microtubules. binding site much sought-after history drug discovery. colchicine-binding inhibitors have been discovered, but use limited due dose-limiting toxicity resistance humans. Combination therapy can be new strategy overcome these drawbacks currently available anticancer drugs. This review discusses significance potential pharmacological stresses necessity finding fight disease.

Language: Английский

Citations

21

Recent advances in stimuli responsive hydrogels for oral disease treatment DOI Creative Commons

Yuzi Wei,

Lingnan Zheng, X. Xie

et al.

Materials & Design, Journal Year: 2024, Volume and Issue: 240, P. 112817 - 112817

Published: Feb. 29, 2024

Oral diseases include oral cancer, periodontitis, endodontium infection, and caries. The cavity is prone to the proliferation of pathogenic bacteria infectious owing its unique environment. During drug-based treatment diseases, saliva can dilute drug formulation, reduce interaction between site action, weaken efficacy. Therefore, searching an effective delivery approach extremely critical urgent. Stimuli responsive hydrogels respond altered environmental conditions under disease states, allowing specific delivery. Accordingly, smart systems prolong duration adverse reactions, decrease frequency administration, improve patient compliance, thereby accelerating recovery. In this review, we discuss different types stimuli for delivery, focusing on their application in management. Further, provide suggestions future research treatment.

Language: Английский

Citations

7

1,2,3-Triazole Clubbed and Dichloro Substituted Novel Aurones as Potential Anticancer Agents Targeting Digestive Enzymes: Design, Synthesis, DFT, ADME and Molecular Docking Studies DOI
Gourav Kumar,

Bhavna Saroha,

P. Arya

et al.

Journal of Molecular Structure, Journal Year: 2024, Volume and Issue: 1319, P. 139460 - 139460

Published: July 26, 2024

Language: Английский

Citations

7

Stimuli-Responsive Nanocomposite Hydrogels for Oral Diseases DOI Creative Commons
Raffaele Conte, Anna Valentino, Silvia Romano

et al.

Gels, Journal Year: 2024, Volume and Issue: 10(7), P. 478 - 478

Published: July 18, 2024

Oral diseases encompassing conditions such as oral cancer, periodontitis, and endodontic infections pose significant challenges due to the cavity's susceptibility pathogenic bacteria infectious agents. Saliva, a key component of environment, can compromise drug efficacy during disease treatment by diluting formulations reducing drug-site interactions. Thus, it is imperative develop effective delivery methods. Stimuli-responsive nanocomposite hydrogels offer promising solution adapting changes in environmental states, thereby enabling targeted delivery. These smart systems have potential enhance efficacy, minimize adverse reactions, reduce administration frequency, improve patient compliance, thus facilitating faster recovery. This review explores various types stimuli-responsive tailored for delivery, with specific focus on their applications managing diseases.

Language: Английский

Citations

6

Combating multidrug resistance of breast cancer with ginsenoside Rh2-irrigated nano-in-thermogel DOI

Jieyu Long,

Wanshan Hu, Tao Ren

et al.

International Journal of Pharmaceutics, Journal Year: 2023, Volume and Issue: 650, P. 123718 - 123718

Published: Dec. 15, 2023

Language: Английский

Citations

13

Natural Taxanes: From Plant Composition to Human Pharmacology and Toxicity DOI Open Access
Ľuboš Nižňanský,

Denisa Osinová,

Roman Kuruc

et al.

International Journal of Molecular Sciences, Journal Year: 2022, Volume and Issue: 23(24), P. 15619 - 15619

Published: Dec. 9, 2022

Biologically active taxanes, present in small- to medium-sized evergreen conifers of various Taxus species, are widely used for their antioxidant, antimicrobial and anti-inflammatory effects, but mostly antitumour effects the treatment solid tumours breast, ovary, lung, bladder, prostate, oesophagus melanoma. More substances found plant extracts have medical potential. Therefore, at beginning this review, we describe methods isolation, identification determination taxanes different parts. One most important is paclitaxel, which summarize pharmacokinetic parameters its formulations. We also toxicological risks during clinical therapy such as hypersensitivity, neurotoxicity, gastrointestinal, cardiovascular, haematological, skin renal toxicity respiratory system. Since effect drug-form PTX enhanced by spp. extracts, published intoxications all fatal poisonings baccata plant. This showed that, despite significant use anticancer treatment, attention should be focused on risk intoxication due ingestion from these plants, commonly our surroundings.

Language: Английский

Citations

22